| Name | Cvs Pharmacy #10215 |
|---|---|
| Organization Name | Cvs Pharmacy Inc |
| Location | 1212 Mcrae Blvd, El Paso, Texas 79925 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (915) 594-4621 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Using a simple form to help focus their attention can help physicians increase the quality and accuracy of clinical breast examinations, increasing the likelihood of detecting cancers missed by mammograms. That's the finding of a new study coming out in the April 1st issue of The American Journal of Medicine.
Navidea Biopharmaceuticals, Inc. today announced that yesterday it received notification from the United States Food and Drug Administration (FDA) that the Prescription Drug User Fee Act (PDUFA) date for 99m-Tc-Tilmanocept, has been modified to September 10, 2012, a 90-day extension from the initial PDUFA date of June 10th.
Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has signed a definitive agreement to acquire Caliper Life Sciences, Inc., a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets, for $10.50 per share, for a total net purchase price of approximately $600 million in cash.
› Verified 6 days ago
| NPI Number | 1861804213 |
| Organization Name | CVS PHARMACY INC |
| Doing Business As | CVS PHARMACY #10215 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1212 Mcrae Blvd, El Paso, TX 79925 |
| Phone Number | 915-594-4621 |
News Archive
Using a simple form to help focus their attention can help physicians increase the quality and accuracy of clinical breast examinations, increasing the likelihood of detecting cancers missed by mammograms. That's the finding of a new study coming out in the April 1st issue of The American Journal of Medicine.
Navidea Biopharmaceuticals, Inc. today announced that yesterday it received notification from the United States Food and Drug Administration (FDA) that the Prescription Drug User Fee Act (PDUFA) date for 99m-Tc-Tilmanocept, has been modified to September 10, 2012, a 90-day extension from the initial PDUFA date of June 10th.
Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has signed a definitive agreement to acquire Caliper Life Sciences, Inc., a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets, for $10.50 per share, for a total net purchase price of approximately $600 million in cash.
› Verified 6 days ago
News Archive
Using a simple form to help focus their attention can help physicians increase the quality and accuracy of clinical breast examinations, increasing the likelihood of detecting cancers missed by mammograms. That's the finding of a new study coming out in the April 1st issue of The American Journal of Medicine.
Navidea Biopharmaceuticals, Inc. today announced that yesterday it received notification from the United States Food and Drug Administration (FDA) that the Prescription Drug User Fee Act (PDUFA) date for 99m-Tc-Tilmanocept, has been modified to September 10, 2012, a 90-day extension from the initial PDUFA date of June 10th.
Cancer progression is commonly thought of as a process involving the growth of a primary tumor followed by metastasis, in which cancer cells leave the primary tumor and spread to distant organs.
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced that it has signed a definitive agreement to acquire Caliper Life Sciences, Inc., a Hopkinton, Massachusetts-based leader in imaging and detection solutions for life sciences research, diagnostics and environmental markets, for $10.50 per share, for a total net purchase price of approximately $600 million in cash.
› Verified 6 days ago
8 Hour Sleep Clinic Type: Medicare Supplier Location: 7430 N Mesa St, El Paso, Texas 79912 Phone: (915) 875-1801 | |
Advant Edge Pharmacy Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1576 Lomaland Dr, El Paso, Texas 79935 Phone: (915) 595-0409 | |
Sav-on Pharmacy #1006 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5200 Montana Ave, El Paso, Texas 79903 Phone: (915) 778-0680 | |
Sav-on Pharmacy #2016 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 11320 Montwood Dr, El Paso, Texas 79936 Phone: (915) 855-9772 | |
Sav-on Pharmacy #2994 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5630 N Desert Blvd, El Paso, Texas 79912 Phone: (915) 845-1422 |